Masao Hashimoto
Overview
Explore the profile of Masao Hashimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McManus D, Valanparambil R, Medina C, Scharer C, McGuire D, Sobierajska E, et al.
Nature
. 2025 Jan;
PMID: 39778710
This study examines the origin and differentiation of stem-like CD8 T cells that are essential for sustained T cell immunity in chronic viral infections and cancer and also have a...
2.
Hatano H, Suzuki M, Sugino M, Nakamura M, Kusaba Y, Tsujimoto Y, et al.
Respir Investig
. 2024 Nov;
62(6):1227-1232.
PMID: 39522366
Background: Nontuberculous mycobacterial pulmonary disease (NTM-PD) varies widely in clinical presentation, and some patients experience hemoptysis. Bronchial artery embolization (BAE) is a treatment option for hemoptysis caused by NTM-PD. However,...
3.
Katsuno T, Kimura M, Terada-Hirashima J, Kazuyama Y, Ikeda M, Moriya A, et al.
J Virol Methods
. 2024 Mar;
326:114909.
PMID: 38452822
This study aimed to evaluate diagnostic accuracy of SARS-CoV-2 RNA detection in saliva samples treated with a guanidine-based or guanidine-free inactivator, using nasopharyngeal swab samples (NPS) as referents. Based on...
4.
McManus D, Valanparambil R, Medina C, Hu Y, Scharer C, Sobierajska E, et al.
Res Sq
. 2024 Feb;
PMID: 38410458
Virus specific PD-1+ TCF-1+ TOX+ stem-like CD8+ T cells are essential for maintaining T cell responses during chronic infection and are also critical for PD-1 directed immunotherapy. In this study...
5.
Iwasaki M, Hashimoto M, Takeuchi J, Kusaba Y, Kimura M, Terada-Hirashima J, et al.
Cureus
. 2024 Feb;
16(1):e52592.
PMID: 38371040
Delays in clearance and rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported in immunocompromised patients. We encountered a case of recurrent, multi-mutational SARS-CoV-2 infection in...
6.
Hashimoto M, Ramalingam S, Ahmed R
Trends Cancer
. 2023 Dec;
10(4):332-346.
PMID: 38129234
There is considerable interest in developing more effective programmed cell death (PD)-1 combination therapies against cancer. One major obstacle to these efforts is a dysfunctional/exhausted state of CD8 T cells,...
7.
Mariniello A, Nasti T, Chang D, Hashimoto M, Malik S, McManus D, et al.
Clin Cancer Res
. 2023 Nov;
30(9):1833-1845.
PMID: 37992307
Purpose: Combination of chemotherapy with programmed cell death 1 (PD-1) blockade is a front-line treatment for lung cancer. However, it remains unknown whether and how chemotherapy affects the response of...
8.
Takeda Y, Naka G, Katsuya Y, Kobayashi K, Suzuki M, Hashimoto M, et al.
BMC Cancer
. 2023 Aug;
23(1):800.
PMID: 37633908
Background: Pemetrexed is an efficacious multi-targeted antifolate with acceptable toxicity for non-squamous non-small cell lung cancer (non-Sq NSCLC) and malignant pleural mesothelioma. Vitamin B12 and folic acid as premedication can...
9.
Gill A, Wang P, Lee J, Hudson W, Ando S, Araki K, et al.
Sci Immunol
. 2023 Aug;
8(86):eadg0539.
PMID: 37624909
PD-1TCF-1 stem-like CD8 T cells act as critical resource cells for maintaining T cell immunity in chronic viral infections and cancer. In addition, they provide the proliferative burst of effector...
10.
Tamura A, Hashimoto M, Hosoi A, Hojo M
Thorac Cancer
. 2023 May;
14(19):1894-1898.
PMID: 37201911
A 50-year-old Japanese woman with advanced breast cancer presented with productive cough and dyspnea while she was receiving a sixth cycle of chemotherapy including atezolizumab. Chest computed tomography revealed bronchiolitis...